DrugsControl Media Services
DrugsControl.org

News Detail

Budget 2024: Government proposes custom duty cut on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 percent to nil (23-07-2024)

New Delhi, 23 July 2024: The government on Tuesday announced to fully exempt three cancer medicines from custom duties.

Union finance minister Nirmala Sitharaman made the announcement while presenting the Union Budget for 2024-25 in the Lok Sabha.

Welcoming ......
View Details

Source : DrugsControl Media Services
Nirmala Sitharaman finance minister Trastuzumab Deruxtecan Durvalumab budget 2024 government

Related News